Fingerprint
Dive into the research topics of 'A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically